Ai Tang Xiao

Ai Tang Xiao

Auto-generated profile, based on publicly available information

Ai Tang Xiao

Tongji Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of Clinical Virology
Verified
Journal Article
Open access
AXAi Tang Xiao
Ai Tang Xiao
YTYi Xin Tong
Yi Xin Tong
CGchun gao
chun gao
LZLi Zhu
Li Zhu
YZYu Jie Zhang
Yu Jie Zhang
SZSheng Zhang
Sheng Zhang
With the spread of Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, its effect on society is amplified. We aimed to describe the viral detection results across different timepoints throughout the disease course. A retrospective study of 301 confirmed COVID-19 patients hospitalized at Tongji Hospital in Wuhan, China, were included. Demographic characteristics of the patients were collected. Upper respiratory specimens (throat and/or nasal swabs) were obtained and analyzed by real-time RT-PCR for SARS-CoV-2 infection. Period of viral infection and the contagious stage were analyzed. Of 301 hospitalized COVID-19 patients, the median age was 58 years and 51.2 % were male. The median period between symptoms presence and positive SARS-CoV-2 RT-PCR results was 16 days (IQR, 10-23, N = 301). The median period between symptoms presence and an effective negative SARS-CoV-2 RT-PCR result was 20 days (IQR, 17-24; N = 216). Infected patient ≥65 years old stayed contagious longer (22 days vs 19 days, p = 0.015). Although two consecutive negative results were confirmed in 70 patients, 30 % of them had positive viral test results for the third time. Using specimens from nasal swabs to run the RT-PCR test showed a higher positive rate than using specimens from throat swabs. This large-scale investigation with 1113 RT-PCR test results from 301 COVID-19 patients showed that the average contagious period of SARS-CoV-2 infected patients was 20 days. Longer observation period and more than 2 series of negative viral test are necessary for patients ≥65 years.

28 February 2020 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
LZLi Zhu
Li Zhu
YTYi Xin Tong
Yi Xin Tong
XXXiangshang Xu
Xiangshang Xu
AXAi Tang Xiao
Ai Tang Xiao
YZYu Jie Zhang
Yu Jie Zhang
SZSheng Zhang
Sheng Zhang
Aims: Adjuvant chemotherapy is recommended for patients with curatively resected colorectal cancer. The aim of this study is to evaluate the impact of unmet supportive care needs and anxiety on the initiation of postoperative adjuvant chemotherapy in colorectal cancer patients. Methods: This is a retrospective study from a single tertiary referral hospital. Patients diagnosed with colorectal cancer who met the inclusion criteria were included. The Hospital Anxiety and Depression Scale (HADS) and modified 34-item Supportive Care Needs Survey (SCNS-SF34) were applied to assess patient’s anxiety level and unmet needs. The time intervals between initiation of adjuvant chemotherapy and operation were recorded. Factors associated with delayed initiation of chemotherapy were investigated in univariate and multivariate analysis. Results: A total of 135 patients with colorectal cancer were included. In total, 16.3% (22/135) and 5.2% (7/135) reported symptoms of anxiety and depression. In multivariate analysis, low to moderate income status, postoperative complications, anxiety, and high level of unmet needs are independent risk factors for late initiation of chemotherapy. Conclusions: Our findings showed that psychological problems such as anxiety and high unmet supportive needs are correlated with delayed initiation of adjuvant chemotherapy in colorectal cancer patients.

1 May 2021 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
CGchun gao
chun gao
LZLi Zhu
Li Zhu
CJCheng Cheng Jin
Cheng Cheng Jin
YTYi Xin Tong
Yi Xin Tong
AXAi Tang Xiao
Ai Tang Xiao
SZSheng Zhang
Sheng Zhang
Re-positive tests for SARS-CoV-2 in Coronavirus Disease 2019 (COVID-19) patients were common. We aimed to investigate the rate and risk factors of recurrent positive detection of SARS-CoV-2 in hospitalized COVID-19 patients. Oropharyngeal and nasopharyngeal swabs (n=3513) were collected to detect SARS-CoV-2 during the hospitalization. We analyzed the recurrent positive rate after consecutive negative results and its relationship to demographic characteristics. Among 599 enrolled COVID-19 patients, the median time for viral RNA shedding was 24 days (IQR, 19-33 days). The positive rate of RT-PCR was 35.9% (215/599), 17.0% (65/383) and 12.4% (23/185) after one, two and three consecutive negative RT-PCR test results respectively. Medians of CT-values of initial positive test, rebound positive after two consecutive negative results, and rebound positive after three consecutive negative results were 28.8, 32.8 and 36.1 respectively. Compare with male patients, females had a significant higher rate of recurrent positive RT-PCR after three consecutive negative results (18.2%, 18/99 vs. 5.8%, 5/86, p=0.013). Older age (≥55 yrs) had a significant higher rate of recurrent positive RT-PCR after one negative result (42.3%, 165/390, vs. 23.9%, 50/209, p<0.001). Nasopharyngeal swab tests produced a higher positive rate than oropharyngeal swab tests (37.3%, 152/408 vs. 35.8%, 1111/3105). Our study revealed the prevalence and dynamic characteristics of recurrent positive RT-PCR to SARS-CoV-2. We showed that around 17.0% (65/383) patients were tested positive for SARS-CoV-2 after two consecutive negative results. Patients with rebound positive RT-PCR test had a low viral load. Older age and female were risk factors for recurrent positive results.

20 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
YAYingqi An
Yingqi An
JGJianping Gong
Jianping Gong
AXAitang Xiao
Aitang Xiao
Purpose The prediction of colorectal cancer (CRC) prognosis greatly influences clinical decision-making. The traditional tumor node metastasis (TNM) staging system has limited prognostic accuracy in CRC patients. This study was designed to develop a more robust prognostic tool to aid in prognosis prediction for CRC patients. Methods Novel prognostic nomogram models were developed based on postoperative pathological findings from 2435 patients who underwent curative colorectal tumor resection. In the development cohort, least absolute shrinkage and selection operator (LASSO) regression was used to select parameters for inclusion in the overall survival (OS) and disease-free survival (DFS) nomograms. Receiver operating characteristic (ROC) analysis, calibration plots, and decision curve analysis (DCA) were utilized to compare performance between the models and the traditional AJCC staging. Results Calibration plots indicated that the nomograms developed had good prognostic prediction capability. ROC analysis revealed that the OS-related nomogram predicted 1-, 3-, and 5-year OS with AUCs of 0.786, 0.776, and 0.803, respectively, compared to 0.768, 0.750, and 0.782, respectively, for the TNM staging system. The DFS nomogram predicted 1-, 3-, and 5-year DFS with AUCs of 0.764, 0.777, and 0.789, respectively, in contrast to 0.762, 0.761, and 0.770 for TNM staging. DCA demonstrated that the developed nomograms provided greater net benefits than did the TNM staging system. Conclusion Our developed prognostic model demonstrated enhanced accuracy in predicting CRC prognosis compared to traditional staging methods. Utilizing this model in postoperative survival prediction for CRC patients could facilitate development of more suitable personalized treatment strategies.